ReviewAnti-cancer drugs2025

Progression of drug resistance or multiple primary lung cancer: a case report and literature review of a patient with mesenchymal-epithelial transition factor exon 14 skipping alterations lung adenocarcinoma.

Liang Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.